Belgium· BE-AMP-SAM589520-00
Bimzelx 160 mg
A bimekizumab product containing bimekizumab, registered in Belgium by UCB Pharma. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Bimekizumab is registered in 14 of 19 countries.
Countries holding a registration under ATC L04AC21 (bimekizumab), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 9 of them publish a price we can compare per daily dose
Bimekizumab · ATC L04AC21
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of bimekizumab costs, country by country.
Normalised to the WHO defined daily dose (5.7 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Bimekizumab · price per daily dose (5.7 mg)
USD · FX 28 Sept 2026
- CH Switzerland$43.14
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Bimekizumab
- Manufacturer
- UCB Pharma
- Country
- Belgium (BE)
- ATC code
- L04AC21
- ATC class
- Bimekizumab
- Defined daily dose
- 5.7 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 3
2 priced- be_apb4383949EUR 1752.14
- be_apb4383931EUR 881.55
- be_apb7735426
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bimekizumab in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaBIMZELXUCB Pharma SA, Brusel
- United KingdomBimzelx 160mg/1ml solution for injection pre-filled pensUCB Pharma Ltd
- IcelandBimzelxUCB Pharma S.A.*
- NorwayBimzelxUCB Pharma S.A. (2)
- PolandBimzelxUCB Pharma S.A.
- SwedenBimzelx 160 mg Injektionsvätska, lösning i förfylld injektionspennaUCB Pharma S.A.
- SpainBIMZELX 160 MG SOLUCION INYECTABLE EN JERINGA PRECARGADAUcb Pharma
- SwitzerlandBimzelx
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Bimzelx
- Liechtenstein · Bimzelx
- Norway · Bimzelx
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82c5831e-5bf1-47cd-86d2-205bf9b0795a GET /v1/drugs/82c5831e-5bf1-47cd-86d2-205bf9b0795a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection in pre-filled pen",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Bimzelx 160 mg",
"name_fr": "Bimzelx 160 mg",
"name_nl": "Bimzelx 160 mg",
"amp_code": "SAM589520-00",
"strengths": [
"160.0000"
],
"pack_count": 4,
"substances": [
"Bimekizumab",
"Sodium Acetate Trihydrate",
"Polysorbate 80"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Bimekizumab",
"authorisation_numbers": [
"EU/1/21/1575/006",
"EU/1/21/1575/007",
"EU/1/21/1575/005",
"EU/1/21/1575/008"
]
}See everything about bimekizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.